[ad_1]
Some medicine accepted by the FDA to deal with diabetes have proven one other potential profit: weight reduction.
A category of drug known as glucagon-like peptide-1 (GLP-1) is thought by model names like Ozempic and Trulicity. GLP-1s are used to deal with diabetes, however some diabetics have additionally misplaced weight throughout remedy.
A brand new drug, Tirzepatide, lately underwent a 72-week trial on non-diabetics and confirmed the potential assist folks reduce weight at proportions as excessive as 21%. Our KSTP medical professional says that is the primary time a drugs might rival getting bariatric surgical procedure, or weight reduction surgical procedure.
KSTP medical professional Dr. Archelle Georgiou offers recommendation about Tirzepatide and related medicine meant to deal with diabetes on this week’s “Inside Your Well being.”
[ad_2]
Supply hyperlink